NIH-funded research R21 grant

How astrocytes influence cocaine use through ion channels

Official title: Regulation of cocaine use by astrocyte voltage-gated channels

Funded at University of Kentucky · NIH-11059984 · Data updated 2026-11-12

This study is looking at how a specific type of brain cell, called astrocytes, changes when someone uses cocaine, and it aims to find out how these changes might help us understand and treat cocaine addiction better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startApril 1, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$221,887
NIH project number5R21DA060354-02
Project IDNIH-11059984 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with cocaine use or addiction, particularly those interested in understanding the biological mechanisms behind their condition.

Less likely to help

Patients who do not use cocaine or are not affected by substance use disorders may not benefit from this research.

What this research studies

This research investigates the role of astrocytes, a type of brain cell, in regulating cocaine use by examining how cocaine affects the signaling mechanisms within these cells. The study focuses on the changes in astrocyte voltage-gated potassium channels and their impact on neuronal signaling after cocaine exposure. By using a rat model of self-administration, the researchers aim to understand how alterations in astrocyte function contribute to cocaine addiction. This could lead to new insights into potential therapeutic targets for treating substance use disorders.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for cocaine addiction by targeting astrocyte signaling pathways.

How similar studies have gone: While the specific focus on astrocyte voltage-gated channels in cocaine use is novel, previous research has shown that targeting glial cells can influence addiction outcomes.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Ortinski, Pavel Ivanovich — University of Kentucky
  • Study coordinator: Ortinski, Pavel Ivanovich

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.